How Has the Protein Chip Market Evolved Historically and What is its Current Size?
The protein chip market has seen considerable growth due to a variety of factors.
• The protein chip market has experienced strong growth in recent years. It is projected to grow from $1.61 billion in 2024 to $1.74 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.9%.
This growth is attributed to the rise in proteomics research, increasing cancer incidence, and expanding applications in clinical diagnostics.
What Does Future Hold for The Protein Chip Market By 2029?
The protein chip market is expected to maintain its strong growth trajectory in upcoming years.
• The protein chip market is expected to grow to $2.32 billion by 2029 at a CAGR of 7.5%.
Growth drivers include personalized medicine, next-gen protein chip technologies, integration with omics technologies, digital health, and wearable devices. Key trends include miniaturization, AI/ML integration, POCT applications, and customization in chip technologies.
What Are The Primary Growth Drivers In The Protein Chip Market?
The escalating need for individualized healthcare is projected to drive the expansion of the protein chip industry. Personalized medicine embodies a healthcare paradigm that seeks to customize treatments and interventions to the distinct needs of each patient. This medical approach has come to light thanks to the swift advancement in 'omics' technology, data amalgamation, genetics, and an enhanced understanding of the importance of patient-specific medications and prevention strategies. Protein chips provide a robust platform for the advancement of personalized healthcare by allowing a full proteomic examination, aiding in biomarker identification, enhancing drug development and the comprehension of responses, and aiding in the development of customized therapeutic approaches. For example, as of October 2022, the Personalized Medicine Coalition's most recent estimates show over 75,000 genetic testing products and 300 individualized medicines available in the market for individuals suffering from various forms of cancer, genetically rare diseases, and several chronic and infectious diseases. Moreover, according to the Personalized Medicine Coalition, a professional membership association in the US, 12 novel customized medications were approved in 2022, making up about 34% of all freshly approved treatments, a substantial surge compared to previous years. Thus, the escalating need for individualized health care fuels the expansion of the protein chip industry.
What Is The Segmentation Of The Global Protein Chip Market?
The protein chip market covered in this report is segmented –
1) By Product: Lab-On-Chip, Integrated System, Arrays, Microarrays System
2) By Technology: Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays
3) By Application: Diagnostics, Proteomics, Antibody Characterization
4) By End User: Hospitals And Clinics, Academic And Research Institutes, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Lab-On-Chip: Diagnostic Lab-On-Chip, Point-Of-Care Lab-On-Chip, Drug Discovery Lab-On-Chip, Clinical Lab-On-Chip
2) By Integrated System: Automated Integrated Systems, Benchtop Integrated Systems, Portable Integrated Systems, Multi-Functional Integrated Systems
3) By Arrays: Protein Arrays, Peptide Arrays, Antibody Arrays, Antigen Arrays
4) By Microarrays System: Dna Microarrays, Rna Microarrays, Protein Microarrays, Antibody Microarrays, Cell-Based Microarrays
Pre-Book The Protein Chip Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Protein Chip Market?
Major players in the protein chip market are pioneering fresh products like automated parallel capillary electrophoresis systems to consolidate their market dominance. Automated parallel capillary electrophoresis systems equal high-end analytical tools for massively parallel isolation and investigation of biomolecules, with a special focus on proteins and nucleic acids. For example, Agilent Technologies Inc. a US firm renowned for manufacturing advanced analytical, research, and diagnostic equipment for labs, unveiled its new ProteoAnalyzer system in January 2024. This newly developed automated parallel capillary electrophoresis instrument for protein analysis comes equipped with unique features. It uses state-of-the-art algorithms for accurate protein identification and profiling, allowing scientists to probe complex biological systems with unmatched precision and speed. The system flaunts superior data visualization tools that simplify results interpretation and speed up insights into cellular functions. Furthermore, it integrates seamlessly with pre-existing workflows, guaranteeing effortless adoption and boosting productivity in proteomics labs.
Who Are the Key Players In The Protein Chip Market?
Major companies operating in the protein chip market are:
• Thermo Fisher Scientific Inc.
• GE Healthcare LLC
• Roche Diagnostics GmbH
• Agilent Technologies Inc.
• Illumina Inc.
• Sigma-Aldrich Corporation (Merck)
• PerkinElmer Inc.
• Shimadzu Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Surmodics Inc.
• Quotient Limited
• OriGene Technologies Inc.
• RayBiotch Inc.
• Sengenics Corporation Pte Ltd.
• Gyros Protein Technologies AB
• Innova Biosciences Limited
• Innopsys S.A.
• CDI Laboratories Inc.
• Microarrays Inc.
• Full Moon BioSystems Inc.
• Arrayit Corporation
• Biotech Support Group LLC
What Are The Regional Insights Into The Protein Chip Market?
North America was the largest region in the global protein chip market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
